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Abstract
Background: Rapid HIV tests provide same-day results and are widely used in HIV testing programs in areas with
limited personnel and laboratory infrastructure. The Uganda Ministry of Health currently recommends the serial
rapid testing algorithm with Determine, STAT-PAK, and Uni-Gold for diagnosis of HIV infection. Using this
algorithm, individuals who test positive on Determine, negative to STAT-PAK and positive to Uni-Gold are reported
as HIV positive. We conducted further testing on this subgroup of samples using qualitative DNA PCR to assess the
potential for false positive tests in this situation.
Results: Of the 3388 individuals who were tested, 984 were HIV positive on two consecutive tests, and 29 were
considered positive by a tiebreaker (positive on Determine, negative on STAT-PAK, and positive on Uni-Gold).
However, when the 29 samples were further tested using qualitative DNA PCR, 14 (48.2%) were HIV negative.
Conclusion: Although this study was not primarily designed to assess the validity of rapid HIV tests and thus only
a subset of the samples were retested, the findings show a potential for false positive HIV results in the subset of
individuals who test positive when a tiebreaker test is used in serial testing. These findings highlight a need for
confirmatory testing for this category of individuals.
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Background
Rapid HIV tests provide quick results [1], usually in less
than 30 minutes, can be performed by any adequately
trained health worker, do not require sophisticated
equipment and can be stored at room temperature (20
°C-
30
°C); [2]. Yet, their diagnostic accuracy has been found
to be comparable to that of Enzyme Linked Immunosor-
bent Assay (ELISA) [1,3]. These advantages make the
rapid HIV tests suitable for use in geographically remote
a r e a sw i t hl i t t l eo rn ol a b o r a t o r yi n f r a s t r u c t u r ea n di n
small hospitals that perform few HIV tests [4]. Determine
and Uni-Gold have a sensitivity of 100% [5,6] and STAT-
PAK is 97.7% [7] sensitive. The specificities for Deter-
mine, Uni-Gold and STAT-PAK are 99.75% [5], 99.7%
[6] and 99.9% [7] respectively. Despite the high sensitivity
and specificity, rapid diagnostic tests have a rare potential
for false negative and false positive test results [8].
The World Health Organization HIV retesting guide-
lines [9] highlight the criteria for retesting persons with
indeterminate and negative HIV test results in order to
reduce the likelihood of false negative HIV results in
early HIV infection [9]. However, these guidelines do not
address the potential for false positive HIV results. This
paper sought to identify the potential for false positive
results in the serial HIV testing algorithm of Determine-
STAT-PAK-Uni-Gold, specifically in the subset of indivi-
duals who tested positive on Determine, negative on
STAT-PAK, and positive on Uni-Gold, by conducting
further testing using Deoxyribonucleic acid Polymerase
chain reaction Qualitative (DNA PCR QL) testing.
Methods
Study procedures
The study was conducted as part of the HIV VCT and
Linkage to Care study in Mulago hospital [10]; a research
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California Los Angeles (UCLA) and University of Califor-
nia San Francisco (UCSF).
Adult patients (≥ 18 years) who had never tested for
HIV, or tested negative at least 1 year prior to recruit-
ment and willing to receive a HIV test were eligible [11].
Ethical approval was obtained from the collaborating
institutions’ Ethical Review boards as well as Uganda
National Council of Science and Technology and each
participant provided verbal and written informed consent
prior to enrolment into the study.
Laboratory testing
HIV counseling and testing was offered after enrollment
and baseline interview. Following pre-test counseling, the
counselor contacted the laboratory technician to draw
blood for HIV testing [11]. HIV testing was done using
the serial testing algorithm using the Determine (Abbott
Laboratories, Abbott Park, IL), STAT-PAK (Chembio
Diagnostics), and Uni-Gold™ Recombigen
® (Figure 1).
Subjects that tested HIV negative on Determine were
reported as negative. Subjects that tested positive on
Determine, negative on STAT-PAK and negative on Uni-
Gold were also reported as negative. According to the
national algorithm, samples that tested positive on Deter-
mine, negative on STAT-PAK and then positive on a
Uni-Gold (tie-breaker test) would be reported as positive
and not retested. However, we conducted further testing
of the latter samples using Deoxyribonucleic acid Poly-
merase chain reaction Qualitative (DNA PCR QL) tests
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Figure 1 Flow diagram of HIV testing algorithm.
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testing.
Statistical analysis
Data captured in a Microsoft Excel spreadsheet was
exported to SAS program for statistical analysis.
Results
Overall, 3,388 individuals were tested for HIV between
May 2008 and June 2011 and 1004 (29.6%) tested HIV
positive (Figure 1). Twenty-four percent of men and
34% of women were HIV positive. Two thirds (62.1%, n
= 2105) of individuals tested negative on Determine and
were reported as negative. Of the 1275 that tested posi-
tive on Determine, 984 also tested positive on the
STAT-PAK and were reported as positive, while 291
were negative on STAT-PAK and were retested with
Uni-Gold. Of the 291 that were retested with Uni-Gold,
262 tested negative and were reported as negative; and
29 tested positive. The 29 samples were further tested
using DNA PCR QL, and 14 (48.2%) tested HIV nega-
tive. DNA PCR has a very high specificity of 99.5%,
[95% CI 99.1-99.9], and is thus an ideal choice for iden-
tifying false positive results [13,14]. Eight participants
who were weakly reactive to the Determine and/or
STAT-PAK test were also further tested using DNA
PCR QL, but were not included among the false positive
results in this study since they would have been retested
with ELISA, according to the current national algorithm
[15].
Discussion
These findings show potential for false positive HIV test
results in the subset of individuals who tested positive
on Determine, negative on STAT-PAK and positive on
Uni-Gold™. DNA PCR QL test may result in occasional
false positives but not false negatives [8], which implies
that the HIV negative DNA PCR QL results in this
study are likely to be accurate. Misdiagnosis of HIV can
lead to psychological difficulties and psychiatric morbid-
ity, has public health and epidemiological implications
and can lead to medico-legal conflict, and should thus
be avoided to the extent possible [16].
This study is limited in that it was not primarily
designed to evaluate the validity of rapid HIV test
results. Since only individuals with positive tie-breaker
tests were further tested using DNA PCR QL, we cannot
estimate the overall false positive rate. However, these
findings highlight an important subgroup of individuals
that require confirmatory testing with DNA PCR or
other highly specific test. There is need for further stu-
dies to examine the occurrence of false positive HIV
test results and mechanisms for minimizing this
challenge.
Conclusion Individuals who test positive on Deter-
mine, negative on STAT-PAK and positive on Uni-Gold
should be considered inconclusive and be further tested
using DNA PCR QL or other validated tests to minimize
the occurrence of false positive HIV test results.
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